Safety and efficacy of US-guided HIFU treatment for HCC patients

Safety and efficacy of US-guided HIFU treatment for HCC patients - Safety and efficacy of HIFU treatment for HCC patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016099

Enrollment

Registered

2015-01-05

Start date

2012-01-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma (HCC)

Interventions

Sonications were performed using a clinical US guided ultrasound surgery system. The Tumor Therapy System used in this study was guided using real-time ultrasonographic imaging. An HIFU imaging unit

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HCC patients admitted at this hospital and signed a informed consent 1) Child-Pugh Score <9 2) Perfomance status:0-1 3) HCC is depicted by ultrasonography 4) HCC diagnosed by imagediagnosis 5)patients with <3 lesions of small HCC and <3 cm diameter 6) patients at the age of 20<

Exclusion criteria

Exclusion criteria: 1) HCC is adjust intestine 2)T-Bil 3.0mg<, <PT 50% 3)bleeding tendency (<Plt 50000/mm3) 4)patients with pregnancy 5)patients with their prognosis <3 months 6)patients the doctor judged as a non-indication from the medical ormental status

Design outcomes

Primary

Measure	Time frame
safety	—

Secondary

Measure	Time frame
efficacy	—

Countries

Japan

Contacts

Public ContactHiroyuki Fukuda

Yokohama City University Medical Center Gastroenterological Center

fukuhiro@yokohama-cu.ac.jp045-261-5656

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026